In both BT474 and in SUM149 mammary carcinoma cells, constitutively active forms of STAT3, AKT and MEK1 were each shown to be a key protective molecular signal to suppress [ruxolitinib + MMF] -induced killing. The gene discussed is AKT1; the disease is breast carcinoma.